mopidamol has been researched along with Lung Neoplasms in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (88.24) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gastpar, H | 1 |
| Cornell, CJ; Forcier, RJ; Forman, WB; Henderson, WG; Martin, JF; Rickles, FR; Van Eeckhout, JP; Zacharski, LR | 1 |
| Ambrus, CM; Ambrus, JL; Gastpar, H | 1 |
| Calman, KC; Gracie, A; Malcolm, A; McLeod, T; Willmott, N | 1 |
| Gomez, J; Maniglia, CA; Sartorelli, AC; Tudor, G | 1 |
| Meehan, KR; Moritz, TE; Rickles, FR; Zacharski, LR | 1 |
| Lichtner, RB; Schirner, M; Schneider, MR | 1 |
| Barnes, S; Bartholomew, MJ; Dixon, R; Gordon, R; Harvey, HA; Lipton, A; Valdivia, D; Walker, B; Warzawski, N; White-Hershey, D | 1 |
| Blaha, H; Dierkesmann, R; Feuerer, W; Gatzemaier, U; Geser, C; Lemme, J; Mall, W; Ritscher, R; Schneider, B; Vallee, D | 1 |
| Bemis, KG; Campbell, JB; Matsumoto, K; Merriman, RL; Shackelford, KA; Tanzer, LR | 1 |
| Hellmann, K; Hutchinson, G; Lichtner, RB | 1 |
| Livingston, RB | 1 |
| Baczek, LA; Ballard, HS; Cornell, CJ; Edwards, RL; Forcier, RJ; Forman, WB; Haakenson, CM; Moritz, TE; Rickles, FR; Zacharski, LR | 1 |
| Hellmann, K; Hutchinson, G; Lichtner, RB; Wedderburn, N | 1 |
| Grimová, J; Mamytbeková, A; Rezábek, K; Svobodová, J | 1 |
| Grimová, J; Kacerovská, H; Mamytbeková, A; Rezábek, K; Svobodová, J | 1 |
3 review(s) available for mopidamol and Lung Neoplasms
| Article | Year |
|---|---|
Platelet aggregation inhibitors and cancer metastasis.
Topics: Animals; Antineoplastic Agents; Blood Platelets; Carcinoma 256, Walker; Cyclic AMP; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Male; Mice; Mopidamol; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Transplantation; Neuraminidase; Platelet Aggregation; Rabbits; Rats; Sarcoma; Vasodilator Agents | 1982 |
Platelets and malignancy. Rationale and experimental design for the VA Cooperative Study of RA-233 in the treatment of cancer.
Topics: Adenocarcinoma; Animals; Anticoagulants; Blood Platelets; Carcinoma, Small Cell; Clinical Trials as Topic; Colonic Neoplasms; Double-Blind Method; Humans; Lung Neoplasms; Mopidamol; Neoplasms; Neoplasms, Experimental; Pyrimidines; Random Allocation | 1982 |
Antiplatelet pyrimido-pyrimidines and metastasis.
Topics: Animals; Blood Platelets; Cyclic AMP; Humans; Lung Neoplasms; Melanoma; Mice; Mopidamol; Neoplasm Metastasis; Platelet Aggregation; Pyrimidines; Rats | 1985 |
4 trial(s) available for mopidamol and Lung Neoplasms
| Article | Year |
|---|---|
Platelets and malignancy. Rationale and experimental design for the VA Cooperative Study of RA-233 in the treatment of cancer.
Topics: Adenocarcinoma; Animals; Anticoagulants; Blood Platelets; Carcinoma, Small Cell; Clinical Trials as Topic; Colonic Neoplasms; Double-Blind Method; Humans; Lung Neoplasms; Mopidamol; Neoplasms; Neoplasms, Experimental; Pyrimidines; Random Allocation | 1982 |
Chemotherapy plus RA233 in the treatment of oat cell lung cancer.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Double-Blind Method; Doxorubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mopidamol; Podophyllotoxin; Prospective Studies; Pyrimidines; Random Allocation; Vincristine | 1989 |
[Adjuvant therapy of non-small cell bronchial cancer with mopidamol].
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Combined Modality Therapy; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mopidamol; Prospective Studies; Pyrimidines; Random Allocation | 1989 |
Effect of mopidamol on survival in carcinoma of the lung and colon: final report of Veterans Administration Cooperative Study No. 188.
Topics: Carcinoma; Clinical Trials as Topic; Colonic Neoplasms; Cyclic AMP; Humans; Lung Neoplasms; Mopidamol; Oncogenes; Prospective Studies; Pyrimidines; Random Allocation | 1988 |
11 other study(ies) available for mopidamol and Lung Neoplasms
| Article | Year |
|---|---|
Effect of phosphodiesterase inhibitors on platelet aggregation and tumor metastasis.
Topics: Adenocarcinoma; Adenosine Diphosphate; Animals; Carcinoma, Ehrlich Tumor; Female; Head and Neck Neoplasms; Humans; Kidney Neoplasms; Lung Neoplasms; Macaca; Male; Mice; Mopidamol; Neoplasm Metastasis; Pentoxifylline; Platelet Aggregation; Rats; Theobromine; Wilms Tumor | 1981 |
Changes in anatomical distribution of tumour lesions induced by platelet-active drugs.
Topics: Animals; Bacterial Infections; Blood Platelets; Female; Lung Neoplasms; Lymphoma; Male; Mice; Mice, Inbred CBA; Mopidamol; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Propionibacterium acnes; Sarcoma 180; Thrombocytopenia; Thrombosis | 1983 |
The effect of 2,6-bis(diethanolamino)-4-piperidinopyrimido [5,4-d]-pyrimidine (RA233) on growth, metastases and lung colony formation of B16 melanoma.
Topics: Animals; Cell Division; Female; Lung Neoplasms; Melanoma; Mice; Mice, Inbred C57BL; Mopidamol; Neoplasms, Experimental; Platelet Aggregation; Pyrimidines | 1982 |
Pretreatment fibrinogen levels are associated with response to chemotherapy in patients with small cell carcinoma of the lung: Department of Veterans Affairs Cooperative Study 188.
Topics: Carcinoma, Small Cell; Cohort Studies; Drug Resistance; Fibrinogen; Fibrinolysin; Fibrinopeptide A; Fibrinopeptide B; Humans; Lung Neoplasms; Mopidamol; Randomized Controlled Trials as Topic; Regression Analysis; Thrombin | 1995 |
The stable prostacyclin analogue Cicaprost inhibits metastasis to lungs and lymph nodes in the 13762NF MTLn3 rat mammary carcinoma.
Topics: Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Epoprostenol; Female; Lung Neoplasms; Lymphatic Metastasis; Mammary Neoplasms, Experimental; Mopidamol; Rats; Rats, Inbred F344 | 1994 |
Drug treatments for metastasis of the Lewis lung carcinoma: lack of correlation between inhibition of lung metastasis and survival.
Topics: Aniline Compounds; Animals; Antineoplastic Agents; Carcinoma; Chemical Phenomena; Chemistry; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Fibrinolytic Agents; Imidazoles; Lung Neoplasms; Mice; Mopidamol; Naphthalenes; Neoplasm Metastasis; Propylamines; Pyrazoles; Pyrazolones; Random Allocation; Tetrahydronaphthalenes | 1989 |
The pyrimido-pyrimidine derivatives RA233 and RX-RA85 affect cell cycle distribution of two murine tumour cell lines.
Topics: Animals; Cell Cycle; Cell Line; Flow Cytometry; Lung Neoplasms; Melanoma, Experimental; Mice; Mopidamol; Phosphodiesterase Inhibitors; Pyrimidines; Tumor Cells, Cultured | 1989 |
Mopidamol in non-small cell lung cancer: anti-oncogene or accident?
Topics: Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Mopidamol; Oncogenes; Pyrimidines | 1988 |
Mopidamol.
Topics: Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Mopidamol; Pyrimidines | 1988 |
Inhibitory action of flurbiprofen and mopidamole on tumor lung metastasis formation in mice.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Flurbiprofen; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Mopidamol; Neoplasm Transplantation; Propionates; Pyrimidines | 1987 |
Antimetastatic effect of flurbiprofen and other platelet aggregation inhibitors.
Topics: Animals; Antineoplastic Agents; Dipyridamole; Flurbiprofen; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Mopidamol; Neoplasm Metastasis; Pentoxifylline; Platelet Aggregation; Propionates; Pyrimidines; Theobromine | 1986 |